Preferred Label : Rozlytrek;
Origin ID : M000654879;
Related record
- See also inter- (CISMeF)
https://www.has-sante.fr/jcms/p_3282231/fr/rozlytrek-entrectinib-tumeurs-solides
2021
false
false
false
France
French
Product containing precisely entrectinib 200 milligram/1 each conventional release
oral capsule (clinical drug)
Product containing precisely entrectinib 100 milligram/1 each conventional release
oral capsule (clinical drug)
evaluation of the transparency committee
entrectinib
protein kinase inhibitors
neoplasms
treatment outcome
insurance, health, reimbursement
entrectinib
Malignant Solid Neoplasm
Rozlytrek
administration, oral
adult
adolescent
aged
Solid neoplasm with neurotrophic receptor tyrosine kinase gene fusion (disorder)
entrectinib
benzamides
indazoles
benzamides
indazoles
---
https://www.has-sante.fr/jcms/p_3282234/fr/rozlytrek-entrectinib-cpnpc
2021
false
false
false
France
Product containing precisely entrectinib 200 milligram/1 each conventional release
oral capsule (clinical drug)
Product containing precisely entrectinib 100 milligram/1 each conventional release
oral capsule (clinical drug)
evaluation of the transparency committee
entrectinib
treatment outcome
insurance, health, reimbursement
entrectinib
Rozlytrek
protein kinase inhibitors
administration, oral
adult
carcinoma, non-small-cell lung
ROS1 Positive
entrectinib
benzamides
indazoles
benzamides
indazoles
---
